A nurse is preparing to administer a second infusion of trastuzumab (Herceptin) to a patient who has breast cancer. The patient tells the nurse that she experienced chills, fever, pain, and nausea after her first infusion. What will the nurse do?

a. Contact the provider to request a CBC to assess for neutropenia.
b. Ensure that oxygen and respiratory support measures are readily available.
c. Reassure the patient that these symptoms will diminish with each infusion.
d. Request an order for an electrocardiogram.


ANS: C
Patients taking trastuzumab may experience a flu-like syndrome with their first infusion that will diminish with subsequent infusions. Neutropenia is not a concern with this drug. Hypersensitivity reactions may occur, but the patient's symptoms are not characteristic of this. Cardiotoxicity may occur, but the symptoms are not characteristic of this.

Nursing

You might also like to view...

A young female member in a therapy group relates to an older female patient as one might to a mother, accusing her of trying to control her whenever the older member offers observations or suggestions to her

Which therapeutic factor of a group is represented by this behavior? a. Instillation of hope b. Existential resolution c. Development of socializing techniques d. Corrective recapitulation of the primary family

Nursing

Another way of communicating findings associated with a research report, other than publication would be through:

A. use of query letters. B. use of the research process. C. oral presentations. D. use of refereed journals.

Nursing

The study of what happens to drugs in the body is

A. medicokinetics. B. pharmacology. C. pharmacy. D. pharmacokinetics.

Nursing

The client tells the nurse that he has been taking Neo-Synephrine for the past month. What is the nurse's highest priority response to the client?

a. Neo-Synephrine can be taken indefinitely while it is still effective. b. Neo-Synephrine should not be taken longer than 24 hours. c. Neo-Synephrine can be taken until symptoms decrease. d. Neo-Synephrine should not be taken for longer than 3 to 5 days.

Nursing